What if we only have 8 mg of norepinephrine (Levophed) for dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Using 8 mg of Norepinephrine for Infusion Preparation

If you only have 8 mg of norepinephrine available, dilute it in 500 mL of D5W to create a 16 mcg/mL concentration, which is the standard concentration recommended by guidelines and allows for appropriate dosing ranges. 1, 2

Standard Dilution Protocol

The FDA-approved preparation method calls for adding 4 mg of norepinephrine to 1,000 mL of 5% dextrose solution to yield 4 mcg/mL. 2 However, when working with 8 mg, you have two practical options:

Option 1: Standard Concentration (Recommended)

  • Add 8 mg to 500 mL of D5W to create 16 mcg/mL concentration 1, 2
  • This is the preferred alternative concentration cited in guidelines for standard use 1
  • Provides adequate volume for typical infusion rates while maintaining stability 3

Option 2: Lower Concentration

  • Add 8 mg to 2,000 mL of D5W to create 4 mcg/mL concentration 2
  • This matches the FDA-recommended concentration exactly 2
  • Use this approach if the patient requires large fluid volumes or prolonged therapy 2

Dosing Considerations With Your Preparation

Starting dose: Begin at 0.5-1 mL/min (8-16 mcg/min) if using the 16 mcg/mL concentration, which translates to approximately 0.1-0.2 mcg/kg/min for a 70 kg adult. 1, 2

Titration: Increase by 0.5 mg/h (approximately 8 mcg/min) every 4 hours as needed, up to a maximum of 3 mg/h (50 mcg/min). 1

Target: Maintain mean arterial pressure ≥65 mmHg or increase MAP by 10 mmHg from baseline. 1, 4

Critical Safety Points

  • Always use dextrose-containing solutions (D5W or D5NS), never saline alone, as dextrose protects against oxidation and loss of potency 2, 3
  • The prepared solution remains chemically stable for 7 days at room temperature under ambient light in either D5W or normal saline, though dextrose is preferred 3
  • Administer through central venous access whenever possible to minimize extravasation risk 1, 2
  • If extravasation occurs, immediately infiltrate phentolamine 5-10 mg diluted in 10-15 mL saline at the site 1

Volume Considerations

With only 8 mg available, your 500 mL bag will provide:

  • Approximately 8 hours of therapy at moderate doses (0.1 mcg/kg/min for 70 kg patient = 7 mcg/min = 26 mL/h)
  • Approximately 3-4 hours at higher doses (0.3 mcg/kg/min = 21 mcg/min = 79 mL/h)

Plan ahead: If the patient requires prolonged vasopressor support or high doses, prepare additional norepinephrine before the current bag is depleted to avoid interruption in therapy. 2

Special Circumstances

For anaphylaxis requiring norepinephrine infusion (after failed epinephrine): Use the alternative 1:100,000 dilution by adding 1 mg to 100 mL saline, administered at 30-100 mL/h (5-15 mcg/min). 1 With 8 mg available, you could prepare 8 separate 100 mL bags for this indication.

For refractory hypotension: When doses exceed 0.5 mcg/kg/min without adequate response, add vasopressin 0.03-0.04 units/min rather than continuing to escalate norepinephrine alone. 1, 4

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stability of norepinephrine infusions prepared in dextrose and normal saline solutions.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2008

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.